Search

STAAR Surgical Co

Fermé

SecteurSoins de santé

26.26 -1.61

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.12

Max

26.73

Chiffres clés

By Trading Economics

Revenu

-8.1M

5.6K

Ventes

-10M

83M

P/E

Moyenne du Secteur

2,455

68.089

BPA

0.26

Marge bénéficiaire

0.007

Employés

921

EBITDA

-14M

5.5K

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+12.42% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-18M

1.2B

Ouverture précédente

27.87

Clôture précédente

26.26

STAAR Surgical Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 nov. 2026, 21:07 UTC

STAAR Surgical Company shares are modestly higher, currently closing near the upper end of their one-month range and above the 20-day moving average.

11 nov. 2026, 21:02 UTC

STAAR Surgical Company shares are sharply higher, breaking a recent trend of higher daily closes since Tuesday's close.

10 nov. 2026, 21:02 UTC

STAAR Surgical Company shares are declining, reversing recent upward momentum and marking a shift from higher daily closes observed since Monday.

9 nov. 2026, 21:03 UTC

STAAR Surgical Company shares fell sharply, continuing a trend of three consecutive lower sessions.

6 nov. 2026, 21:02 UTC

Macro Event

STAAR Surgical Company shares fell sharply, breaking a trend of higher daily closes, amid mixed macroeconomic signals despite an improvement in consumer sentiment.

5 nov. 2026, 21:04 UTC

News

STAAR Surgical shares are declining amid a broader market downturn in the Health Care Supplies sector, despite a brief recovery earlier in the session.

4 nov. 2026, 23:21 UTC

News

STAAR Surgical Company announces a $50 million share repurchase program and reports third-quarter net sales of $83.4 million, exceeding expectations.

28 oct. 2026, 20:02 UTC

STAAR Surgical Company is trading higher, maintaining its position above the 20-day moving average after five consecutive daily closes.

27 oct. 2026, 20:07 UTC

News

STAAR Surgical Company saw a notable increase in share price following the trading of 2k contracts of November 30 calls, raising implied volatility to 67.

26 oct. 2026, 20:06 UTC

STAAR Surgical Co shares advanced, maintaining a notable gain since Friday's close, despite settling lower after reaching a peak during Monday's session.

22 oct. 2026, 20:07 UTC

STAAR Surgical Co shares are advancing, reflecting a steady ascent throughout Thursday, contributing to a cumulative return exceeding 4% since Wednesday's close.

20 oct. 2026, 20:08 UTC

STAAR Surgical Co shares advanced, maintaining a strong position above its 20-day moving average, after gaining since Monday's close.

19 oct. 2026, 20:07 UTC

STAAR Surgical Co shares advanced, closing higher after pulling back earlier, with a cumulative return of nearly 3% since Friday's close.

16 oct. 2026, 20:07 UTC

STAAR Surgical Co shares are declining, having sharply dropped after an early peak, and remain below their 20-day moving average since Thursday's close.

15 oct. 2026, 20:07 UTC

STAAR Surgical Co shares are advancing, maintaining a notable gain since Wednesday's close, despite a slight pullback earlier in the session.

14 oct. 2026, 20:02 UTC

News

STAAR Surgical Co. shares are higher as the company appoints Andrew Pilon, OD, as vice president of business development to enhance its innovation strategy.

13 oct. 2026, 20:08 UTC

News

Shares of STAAR Surgical Co are declining amid a broader market trend lower, despite the appointment of Andrew Pilon, OD, as vice president of business development.

6 oct. 2026, 20:06 UTC

STAAR Surgical Co. shares fell sharply mid-morning, continuing a downward trend since Monday, despite remaining above the 20-day moving average.

2 oct. 2026, 20:07 UTC

STAAR Surgical Co shares are higher, rebounding from an earlier pullback, supported by a broadly advancing market and declining U.S. Treasury yields.

1 oct. 2026, 20:07 UTC

STAAR Surgical Co shares are declining, continuing a trend lower since Wednesday's close, despite an earlier rebound from a session low.

30 sept. 2026, 19:35 UTC

STAAR Surgical Co's shares are near unchanged, experiencing fluctuations including an earlier dip and recovery, while remaining above the 20-day moving average.

29 sept. 2026, 20:02 UTC

Social Media
News

STAAR Surgical Co shares advanced sharply after Stifel upgraded the rating from Hold to Buy and raised the price target from $28 to $31.

25 sept. 2026, 20:02 UTC

News
Social Media

STAAR Surgical Co's Board has authorized a $50 million share repurchase program, contributing to the stock's sharp advance during market hours.

24 sept. 2026, 20:01 UTC

STAAR Surgical Co shares fell sharply, retracing from earlier gains and trading below its 20-day moving average during Thursday's session.

23 sept. 2026, 20:07 UTC

STAAR Surgical Co shares fell sharply Wednesday, continuing a decline that has seen them significantly drop since Tuesday's close and remain near their one-month low.

22 sept. 2026, 20:06 UTC

STAAR Surgical Co is advancing in today's trading session, reflecting a cumulative increase since Monday, despite earlier volatility and remaining below its 20-day moving average.

21 sept. 2026, 20:06 UTC

STAAR Surgical Co's shares are declining, marking a six-session losing streak and remaining significantly below the 20-day moving average.

18 sept. 2026, 20:02 UTC

STAAR Surgical Co shares fell sharply, continuing a downward trend over the past four days and remaining significantly below their 20-day moving average.

17 sept. 2026, 20:02 UTC

STAAR Surgical Co shares fell sharply on Thursday, breaking from a recent trend of higher daily closes amid contrasting upward momentum in previous sessions.

16 sept. 2026, 20:10 UTC

STAAR Surgical Co shares fell, retracing from a brief peak earlier in the day and remaining below the 20-day moving average.

Comparaison

Variation de prix

STAAR Surgical Co prévision

Objectif de Prix

By TipRanks

12.42% hausse

Prévisions sur 12 Mois

Moyen 29.667 USD  12.42%

Haut 34 USD

Bas 23 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat